BENEFIT (7-year follow-up) (2016) — Trial Summary

BENEFIT (7-year follow-up) (2016): Final 7-year (84-month) results of the phase 3 BENEFIT trial comparing more- and less-intensive belatacept regimens with cyclosporine in kidney-transplant recipients (n=666).

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.